Nancy Keating, MD, MPH, Professor of Health Care Policy, Harvard Medical School, Practicing General Internist, Brigham and Women's Hospital

Overview

As policy makers and payers seek to improve the value of care delivered to Americans, there is increasing interest in Alternate Payment Models (APM). Since July 2016, more than 180 practices entered into the Oncology Care Model (OCM), an APM with Centers for Medicare & Medicaid Services (CMS) that provides practices and the opportunity to receive performance-based payments for episodes of care surrounding chemotherapy administration to Medicare beneficiaries with cancer.

In this webinar, Dr. Nancy Keating discussed how OCM focuses on 6-month episodes of care for fee-for-service Medicare beneficiaries with cancer, which are triggered by the administration of anti-cancer therapy.  As a member of the OCM Evaluation Team, she reviewed some findings of the early impact of the OCM, an APM focused on specialty care, on total costs of care, service utilization and quality and shared plans for upcoming analyses. This webinar can aid health care business leaders in understanding opportunities and challenges of using APMs to improve the value of oncology care delivery.

About the Presenter

Nancy L. Keating, MD, MPH is a professor of health care policy and medicine at Harvard Medical School and a primary care physician at Brigham and Women’s Hospital. Dr. Keating’s research examines provider, patient and health system factors that influence the delivery of high-quality care for individuals with cancer. Dr. Keating is currently evaluating the Center for Medicare and Medicaid Service’s Oncology Care Model, a new payment and delivery model for oncology practices administering chemotherapy. She is also a longstanding member of the Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium, funded by the National Cancer Institute (NCI). She is an associate editor at the Journal of the National Cancer Institute, a member of the editorial board of the Journal of Geriatric Oncology and a member of the National Comprehensive Cancer Center Senior Oncology Guideline Panel.